Identification of a Key Residue Mediating Bone Morphogenetic Protein (BMP)-6 Resistance to Noggin Inhibition Allows for Engineered BMPs with Superior Agonist Activity
Open Access
- 1 April 2010
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 285 (16), 12169-12180
- https://doi.org/10.1074/jbc.m109.087197
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Bone morphogenetic proteins (BMPs): From morphogens to metabologensCytokine & Growth Factor Reviews, 2009
- Design of second generation therapeutic recombinant bone morphogenetic proteinsCytokine & Growth Factor Reviews, 2009
- The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signalingCytokine & Growth Factor Reviews, 2009
- RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitroJournal of Bone and Mineral Metabolism, 2009
- BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem CellsJournal of Biological Chemistry, 2008
- BMP-3 and BMP-6 Structures Illuminate the Nature of Binding Specificity with Receptors,Biochemistry, 2007
- Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: Experimental studies in the non-human primate Papio ursinusCytokine & Growth Factor Reviews, 2005
- BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talkCytokine & Growth Factor Reviews, 2005
- The L45 loop in type I receptors for TGF‐β family members is a critical determinant in specifying Smad isoform activationFEBS Letters, 1998
- Bone: Formation by AutoinductionScience, 1965